Clune--Associates

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-04-28
Total Holdings
141
Total Value
325596867
Accession Number
0001754960-25-000250
Form Type
13F-HR
Manager Name
Clune--Associates
Data Enrichment
55% identified
78 identified63 unidentified

Holdings

141 positions • $325.6M total value
Manager:
Search and click to pin securities to the top
Page 8 of 8
Acumen Pharmaceuticals, Inc.
Shares:16.5K
Value:$18.1K
% of Portfolio:0.0% ($18.1K/$325.6M)